Thank you for this proposal @Arbitrum. It makes sense for the Foundation to remove the amortized cost cap if continuing to subsidize Nova no longer delivers meaningful benefits. We’re aligned on that point.
That said, since one of Nova’s original selling points was its ultra-low fees, it feels appropriate to open a broader conversation about Nova’s trajectory. What is the roadmap for Nova now that its cost advantage over Arbitrum One has narrowed? It’s been noted that Nova carries a “lower strategic priority within the Arbitrum ecosystem”. Is Nova’s fate already set in stone, or are there plans to reinvigorate its value proposition over the longer term?